Business

Business Strategy

Joint venture collaboration with Big Pharma
Generation of early cash flow
Up-front, R&D, milestone-based payments and royalties
Alliances with leaders in veterinary OB/Gyn markets
Licensing of independent development of drug products for other specific indications

Target Markets

Big Pharma
Health care Insurers
Health care Providers
Patients (Mother and Baby)

Strategic Partnerships

Companies invested in OB/Gyn:
Abbott and Schering (tocolytics)
Johnson & Johnson (contraceptives, surfactants)
Ferring (infertility, preterm labor) ö bundling
Organon and Akzo Nobel (contraceptives)
Other companies interested in entering OB/Gyn
Animal Pharma companies
Companies that will license these molecules for other indications